Lifyorli 150 MG, 1-Dose Pack

RxCUI: 2739556
RxNorm name: Lifyorli 150 MG, 1-Dose Pack
Display name: Lifyorli 150 MG, 1-Dose Pack
Full name: Lifyorli 150 MG, 1-Dose Pack
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lifyorli	RELACORILANT	Corcept Therapeutics Incorporated	6fcebfb5-19d6-4f63-b852-999d68a13729	2026-03-26	Warnings, Adverse reactions	Exact identifier rxcui: 2739556

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6fcebfb5-19d6-4f63-b852-999d68a13729	Lifyorli 150 MG, 1-Dose Pack	PSN	1	These highlights do not include all the information needed to use LIFYORLI safely and effectively. See full prescribing information for LIFYORLI. LIFYORLI TM (relacorilant) capsules, for oral use Initial U.S. Approval: 2026	20260326
6fcebfb5-19d6-4f63-b852-999d68a13729	{1 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 2 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 1-Dose Supply]	BPCK	1	These highlights do not include all the information needed to use LIFYORLI safely and effectively. See full prescribing information for LIFYORLI. LIFYORLI TM (relacorilant) capsules, for oral use Initial U.S. Approval: 2026	20260326
6fcebfb5-19d6-4f63-b852-999d68a13729	Lifyorli 150 MG, 1-Dose Pack	SY	1	These highlights do not include all the information needed to use LIFYORLI safely and effectively. See full prescribing information for LIFYORLI. LIFYORLI TM (relacorilant) capsules, for oral use Initial U.S. Approval: 2026	20260326